+971 55 586 7466
EN|AR
HomeConditionsPsoriasis Treatment in JVC
PSORIASIS TREATMENT · DHA-LICENSED · JUMEIRAH VILLAGE CIRCLE

Psoriasis treatment in JVC, Dubai. Specialist care including modern biologic treatments for lasting improvement

Specialist psoriasis treatment at our Jumeirah Village Circle (JVC) clinic — walking distance from Circle Mall. DHA-licensed consultant dermatologists treating all psoriasis presentations, including chronic plaque, scalp, nail, guttate, inverse, pustular, palmoplantar, and psoriatic arthritis considerations. Comprehensive care from topicals through modern biologic treatments (adalimumab, secukinumab, ustekinumab, ixekizumab, guselkumab, risankizumab) that have transformed outcomes.

Psoriasis treatment consultation at Vedara Care JVC Dubai with consultant dermatologist

Modern psoriasis treatment is transformative.

The last decade has transformed psoriasis treatment. Modern biologic medications targeting specific inflammatory pathways achieve outcomes — clear or nearly clear skin — that were previously not possible.

DHA-licensed consultant dermatologists
All psoriasis types treated
Access to modern biologic treatments
Walking distance from Circle Mall, JVC

THE QUICK ANSWER

Psoriasis treatment at Vedara Care, in one paragraph.

Psoriasis treatment at Vedara Care Polyclinic in Jumeirah Village Circle (JVC), Dubai — walking distance from Circle Mall — is specialist evidence-based dermatology care delivered by DHA-licensed consultant dermatologists with substantial expertise across all psoriasis presentations. We treat: chronic plaque psoriasis (the most common form), scalp psoriasis, nail psoriasis, guttate psoriasis, inverse psoriasis, pustular psoriasis, palmoplantar psoriasis, and considerations for psoriatic arthritis. Our approach combines comprehensive assessment (skin, nails, joints, associated systemic conditions), evidence-based topical treatments, phototherapy where available, oral systemic treatments (methotrexate, cyclosporine, acitretin, apremilast), and modern biologic treatments — including TNF inhibitors (adalimumab, etanercept), IL-17 inhibitors (secukinumab, ixekizumab), IL-23 inhibitors (guselkumab, risankizumab, tildrakizumab), and IL-12/23 inhibitor (ustekinumab). Realistic framing: well-controlled psoriasis with clear or nearly clear skin is achievable for most patients with modern treatments. Sustained partnership approach with regular follow-up. Medical psoriasis treatment is covered by most insurance with appropriate justification. Patients travel to our JVC clinic from across Dubai for specialist psoriasis care.

Medically reviewed by Lead Consultant Dermatologist, MD, DHA-Licensed · Last updated July 2026

UNDERSTANDING PSORIASIS

What psoriasis actually is — and why modern treatment has transformed outcomes.

Understanding psoriasis as autoimmune condition rather than skin problem guides effective treatment selection and realistic expectations.

Psoriasis is a chronic autoimmune condition primarily affecting the skin but with systemic implications. Understanding the underlying immune dysfunction — not just the skin manifestations — guides effective treatment.

The autoimmune basis

Psoriasis is fundamentally an immune-mediated condition where the immune system produces excess inflammation in the skin. Specific inflammatory pathways involving T-helper 17 cells, interleukin 17 (IL-17), interleukin 23 (IL-23), and tumour necrosis factor alpha (TNF-α) drive the characteristic skin changes. This immunological understanding transformed treatment — modern biologic medications target these specific pathways rather than broadly suppressing immunity like older treatments. Genetic predisposition plays a substantial role; environmental triggers activate the condition in susceptible individuals.

The accelerated skin cell turnover

Normal skin cells mature and shed over approximately 28 days. In psoriasis lesions, this process accelerates dramatically to 3–5 days — immature skin cells accumulate faster than they can be shed. Understanding this accelerated turnover explains why topical treatments containing vitamin D analogs (regulating skin cell maturation) work effectively.

Common triggers requiring identification

Multiple factors can trigger or worsen psoriasis: stress (well-established trigger, particularly relevant in expatriate lifestyle), infections (streptococcal throat infections particularly trigger guttate psoriasis), skin injury (Koebner phenomenon), medications (beta blockers, lithium, antimalarials), alcohol, smoking, weather changes, and hormonal changes. Identifying your specific triggers guides practical management.

Psoriasis as systemic condition — beyond the skin

Recognition of psoriasis as systemic rather than purely skin condition transformed care. Associated conditions requiring awareness: psoriatic arthritis (affects approximately 30% of psoriasis patients), cardiovascular disease risk, metabolic syndrome, depression and anxiety, and inflammatory bowel disease. Comprehensive assessment considers these dimensions.

Dubai-specific factors affecting psoriasis

Dubai environment presents specific considerations: sun exposure (moderate UV often improves psoriasis), climate effects (heat and humidity affect variably), expatriate stress patterns, access to modern biologic treatments, and cultural clothing patterns affecting psoriasis distribution in some patients.

Why psoriasis is chronic — but well-controlled today

Psoriasis is a chronic condition without permanent cure in most cases. However, modern treatments — particularly biologic medications — achieve outcomes previously not possible: clear or nearly clear skin, sustained improvement, dramatic quality-of-life improvement. Patients who have lived with substantial psoriasis for years often achieve transformative improvement with modern specialist care.

"The last decade transformed psoriasis treatment. Patients who have lived with substantial psoriasis for years often achieve clear or nearly clear skin with modern biologic treatments — outcomes previously thought impossible."
Psoriasis autoimmune inflammation IL-17 IL-23 pathway illustration

INFLAMMATORY PATHWAYS

IL-17 Inhibitors
Secukinumab · Ixekizumab
IL-23 Inhibitors
Guselkumab · Risankizumab
TNF-α Inhibitors
Adalimumab · Etanercept
PSORIASIS TYPES

The psoriasis presentations we treat at our JVC clinic.

Different psoriasis types have different patterns and treatment considerations. Accurate diagnosis guides effective treatment selection.

01

Chronic Plaque Psoriasis

Typical presentation:

  • Well-demarcated red plaques with silvery scaling on elbows, knees, scalp, lower back
02

Scalp Psoriasis

Typical presentation:

  • Thick scaling on scalp, sometimes extending beyond hairline
03

Nail Psoriasis

Typical presentation:

  • Nail pitting, discoloration, thickening, separation — often multiple nails affected
04

Guttate Psoriasis

Typical presentation:

  • Multiple small round lesions distributed over trunk and limbs, often after infection
05

Inverse (Flexural) Psoriasis

Typical presentation:

  • Smooth red patches in skin folds — armpits, groin, under breasts
06

Pustular Psoriasis

Typical presentation:

  • Sterile pustules on red background, localised or widespread
07

Palmoplantar Psoriasis

Typical presentation:

  • Thickened scaling on palms and soles, sometimes with cracks and pustules
08

Erythrodermic & Severe Psoriasis

Typical presentation:

  • Extensive skin involvement, systemic symptoms, substantial quality-of-life impact
TREATMENT OPTIONS

The evidence-based treatments we use for psoriasis.

Foundation — moisturisation and skincare

Regular moisturiser application addresses barrier compromise and helps reduce scaling. Emollients applied multiple times daily. Coal tar-containing moisturisers can provide additional benefit. Gentle skincare avoiding irritants that trigger the Koebner phenomenon. Foundation supports all other treatments.

Topical treatments

Cornerstone for mild-moderate psoriasis and adjunctive for severe. Topical corticosteroids — matched potency to location and severity. Vitamin D analogs (calcipotriol, calcitriol) — regulate skin cell maturation, often combined with corticosteroids. Calcineurin inhibitors — particularly useful for facial and flexural psoriasis. Coal tar preparations, salicylic acid, and newer topical agents. Combination and rotation strategies optimise outcomes.

Phototherapy where available

Established treatment approach. Narrow-band UVB phototherapy — standard for moderate psoriasis; typically 2–3 sessions weekly for 8–12 weeks. PUVA therapy — combining psoralen with UVA; effective but with more monitoring requirements. Excimer laser — targeted phototherapy for limited psoriasis. Phototherapy can be excellent option for moderate psoriasis avoiding systemic treatments.

Oral systemic treatments

For moderate-severe psoriasis inadequately controlled with topicals. Methotrexate — established option; requires monitoring for liver and blood count effects. Cyclosporine — rapid onset for severe flares; typically shorter-term use. Acitretin — oral retinoid; useful particularly for pustular and palmoplantar psoriasis. Apremilast — oral PDE4 inhibitor; well-tolerated generally; useful for moderate psoriasis.

Biologic treatments — the transformation

Modern biologics have revolutionised psoriasis treatment. Targeting specific inflammatory pathways, they achieve outcomes previously not possible. TNF-α inhibitors: adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade). IL-17 inhibitors: secukinumab (Cosentyx), ixekizumab (Taltz), brodalumab. IL-23 inhibitors: guselkumab (Tremfya), risankizumab (Skyrizi), tildrakizumab (Ilumya). IL-12/23 inhibitor: ustekinumab (Stelara). Many patients achieve clear or nearly clear skin.

Comprehensive assessment for systemic implications

Psoriasis is a systemic condition. Comprehensive assessment includes psoriatic arthritis screening, cardiovascular risk assessment, metabolic syndrome screening, mental health awareness, and lifestyle counselling (alcohol, smoking, stress management, weight management). Comprehensive approach beyond skin treatment.

Your Treatment Plan

Comprehensive assessment (skin, nails, joints)
Psoriasis type identification
Trigger identification
Realistic expectations
Regular follow-up

MODERN BIOLOGIC ACCESS

  • TNF-α inhibitors
  • IL-17 inhibitors
  • IL-23 inhibitors
  • IL-12/23 inhibitors
  • Insurance authorisation support

REALISTIC TIMELINES

Initial improvement
4-8 weeks
Substantial control
12-16 weeks
Biologic response
12-16 weeks
Sustained maintenance
Ongoing
Book Psoriasis Consultation
REALISTIC EXPECTATIONS

How psoriasis treatment progresses over time.

Modern treatment has transformed psoriasis outcomes. Understanding realistic timelines and sustained management guides commitment to effective treatment.

01
Phase 1

Comprehensive Assessment & Initiation

WEEKS 0-4

Thorough consultation identifying psoriasis type, severity, and associated conditions (particularly psoriatic arthritis screening). Treatment plan initiated including topical treatments, lifestyle recommendations, phototherapy consideration, or systemic treatment discussion. For patients starting biologics: insurance authorisation process, patient education, and first doses begin.

02
Phase 2

Achieving Control

WEEKS 4-16

Steady improvement for most patients with treatment matched to disease severity. Topical therapies usually show gradual improvement over several weeks. Systemic treatments typically demonstrate benefit within 8–12 weeks. Biologic therapies often provide significant improvement between 12–16 weeks, with many patients achieving clear or nearly clear skin. Treatment adjustments are made according to individual response.

03
Phase 3

Optimising & Sustaining Control

MONTHS 4-12

Well-controlled psoriasis is achieved for many patients receiving appropriate treatment. Care transitions from active control to long-term maintenance. Patients using biologic therapies continue regular monitoring for treatment effectiveness and safety while maintaining improvements in skin symptoms and quality of life. Associated conditions are also monitored throughout this phase.

04
Phase 4

Sustained Long-Term Care

YEAR 1 ONWARDS

Long-term partnership with your dermatologist continues through regular follow-up visits and treatment reviews. Some patients remain on maintenance treatment, while others require adjustments depending on disease activity. Ongoing monitoring helps maintain disease control, minimise flare-ups, monitor medication safety, and support long-term skin health and overall wellbeing.

These timelines describe typical treatment patterns. Individual progress varies depending on psoriasis type, severity, chosen treatment approach, adherence, and individual response. The strongest predictor of long-term success is consistent partnership with a specialist dermatologist, appropriate treatment selection, and realistic expectations regarding chronic disease management.

PATIENT VOICES

Real psoriasis outcomes with specialist care.

"Chronic plaque psoriasis for 15 years, affecting substantial areas of my body. Multiple previous treatments providing partial improvement at best. The consultation was thorough — comprehensive assessment including joint evaluation identified mild psoriatic arthritis I had not connected. Started on IL-17 inhibitor. Within 4 months, dramatic improvement — clearer skin than I had in 15 years. Joint symptoms improved. Quality of life transformed. The access to modern treatments combined with specialist expertise completely changed my life."

MALE PATIENT, 47

Chronic Plaque Psoriasis with Psoriatic Arthritis · Biologic Treatment

Downtown Dubai · February 2026

"Severe scalp and nail psoriasis for years, socially isolating despite being a professional adult. Vedara's assessment identified extent of nail involvement I had not appreciated as connected to my scalp condition. Started biologic treatment addressing both. Progress remarkable: scalp cleared substantially over 3-4 months, nails improving over 8-10 months. Confidence at work transformed. The specialist recognition of nail psoriasis as significant condition warranting systemic treatment made the difference previous providers had not addressed."

FEMALE PATIENT, 38

Severe Scalp and Nail Psoriasis · Biologic Treatment

Dubai Marina · January 2026

"Palmoplantar psoriasis affecting my ability to work in healthcare with hand-intensive requirements. Vedara's approach was comprehensive: identified aggravating factors including stress and specific occupational exposures, initiated appropriate systemic treatment with monitoring, coordinated with occupational health for practical modifications. Substantial improvement over 6 months allowing sustained professional practice. The combination of specialist medical care and practical occupational support made the difference."

FEMALE PATIENT, 44

Palmoplantar Psoriasis · 8-Month Programme

Al Barsha South · March 2026

4.9 / 5.0

Google Rating

400+

Psoriasis Patients Treated

Full Range

Modern Biologic Treatments

Comprehensive

Systemic Assessment

THE TEAM

Consultant dermatologists for psoriasis treatment at our JVC clinic.

Psoriasis treatment is delivered by DHA-licensed consultant dermatologists with substantial expertise across all psoriasis presentations, all Fitzpatrick skin types, and modern treatment approaches including biologics. Female and male dermatologists available. Languages: Arabic, English, Hindi, Urdu.

Dr. Sarah Al-Rashidi consultant dermatologist psoriasis specialist Vedara Care JVC

Dr. Sarah Al-Rashidi, MD

DHA-Licensed · Consultant Dermatologist
PsoriasisBiologicsSystemic Treatments

Specialist expertise in moderate-severe psoriasis and biologic treatment initiation. Extensive experience with psoriatic arthritis screening.

Languages spoken
Arabic, English
Dr. Priya Menon consultant dermatologist psoriasis specialist Vedara Care JVC

Dr. Priya Menon, MD

DHA-Licensed · Consultant Dermatologist
Autoimmune SkinBiologicsNail Psoriasis

Expertise in autoimmune dermatology with substantial experience treating diverse skin types including Fitzpatrick IV–VI.

Languages spoken
English, Hindi, Malayalam
Dr. Khaled Hassan consultant dermatologist psoriasis specialist Vedara Care JVC

Dr. Khaled Hassan, MD

DHA-Licensed · Consultant Dermatologist
PsoriasisPhototherapySystemic Treatments

Specialist in phototherapy protocols and oral systemic treatments. Extensive experience in psoriasis with scalp and nail involvement.

Languages spoken
Arabic, English, French
TRANSPARENT PRICING

What psoriasis treatment at our JVC clinic costs.

Initial psoriasis consultation with comprehensive assessment (45–60 min)

AED [X]

Follow-up consultation

AED [X]

Treatment monitoring visit

AED [X]

Comprehensive systemic assessment (psoriatic arthritis, cardiovascular risk)

AED [X]

Nail psoriasis specific assessment

AED [X]

Topical treatment prescription and education

AED [X]

Phototherapy course (where available)

From AED [X]

Oral systemic treatment monitoring

From AED [X]/month

Biologic treatment consultation and initiation

Consultation required

Biologic treatment ongoing monitoring

From AED [X]/month

Comprehensive 6-month psoriasis management programme

From AED [X]

Comprehensive 12-month programme with systemic support

From AED [X]

COMMON QUESTIONS

What patients ask about psoriasis treatment.

For broader dermatology questions, see our dermatology clinic page.

Ask Our Team on WhatsApp

Psoriasis is a chronic autoimmune condition where the immune system produces excess inflammation in the skin, causing characteristic thick red plaques with silvery scaling. It involves specific inflammatory pathways (IL-17, IL-23, TNF-α). Genetic predisposition combined with environmental triggers activates the condition. It is not contagious and affects approximately 2–3% of the global population.

Honest answer: complete permanent cure is uncommon. However, modern treatments — particularly biologic medications — achieve outcomes previously not possible: clear or nearly clear skin, sustained improvement, dramatic quality-of-life improvement. Many patients achieve excellent long-term control with modern specialist care. Realistic framing: chronic condition requiring ongoing management; excellent control is very achievable.

Biologics are targeted medications that block specific inflammatory pathways involved in psoriasis. Modern biologics target IL-17, IL-23, or TNF-α specifically rather than broadly suppressing immunity. Administered by subcutaneous injection at intervals (some monthly, some quarterly). Excellent efficacy — many patients achieve clear or nearly clear skin. Well-tolerated generally; require specialist prescription, patient selection, and monitoring.

Initial improvement varies by treatment approach. Topical treatments: gradual improvement over 4–8 weeks. Systemic treatments: benefit typically at 8–12 weeks. Biologic treatments: substantial improvement often at 12–16 weeks, with many patients achieving clear or nearly clear skin. Individual variation occurs substantially.

Our DHA-licensed clinic is in Jumeirah Village Circle (JVC), Dubai — walking distance from Circle Mall, three minutes from FIVE Jumeirah Village Hotel, five minutes from JSS Private School. Patients travel to us from JVT, Al Barsha South, Sports City, Motor City, Arjan, Dubai Hills, Marina, Downtown, Palm Jumeirah, Mirdif, and across Dubai for specialist psoriasis care.

No. Psoriasis is not contagious and cannot be transmitted through physical contact. It is an autoimmune condition — the patient's own immune system produces the skin changes. This is important education for patients experiencing social difficulties or misconceptions from others.

Yes — psoriatic arthritis affects approximately 30% of psoriasis patients. Symptoms include joint pain, morning stiffness lasting more than 30 minutes, swollen joints, and back pain. Early identification and treatment prevents joint damage. Our comprehensive psoriasis consultation includes psoriatic arthritis screening and coordination with rheumatology when concerns are identified.

Yes — we have substantial expertise across all Fitzpatrick skin types. Particular considerations for darker skin: psoriasis may present differently (less obvious redness, more prominent pigmentation changes), and post-inflammatory hyperpigmentation is a significant concern following resolution. All modern treatments including biologics work effectively across skin types.

Biologics are generally well-tolerated. Main considerations: increased infection risk (typically minor infections rather than serious); tuberculosis and hepatitis screening required before starting; injection site reactions common but usually mild. Serious side effects are uncommon. We discuss specific biologic risks and benefits during consultation and provide ongoing monitoring.

Most Dubai insurance plans cover medical psoriasis treatment with appropriate justification. Biologic treatments — highly effective but substantial cost — often require prior authorisation. Coverage varies by insurance plan and specific biologic. We are direct-billing partners with seven major insurers and support patients through authorisation processes. WhatsApp your insurance card before booking for specific coverage discussion.

When used appropriately, yes. Appropriate use means matched potency to location, appropriate application patterns, and avoiding continuous long-term high-potency use. Concerns arise mainly with inappropriate high-potency use. Modern approach often combines topical steroids with vitamin D analogs in fixed combination products for optimised outcomes.

Phototherapy uses specific UV wavelengths to treat psoriasis — narrow-band UVB is the standard approach. Effective for moderate psoriasis avoiding systemic treatments. Typically 2–3 sessions weekly for 8–12 weeks. Requires appropriate equipment. Please discuss availability at our clinic during your consultation.

Substantially. Psoriasis is associated with increased anxiety, depression, and social difficulties. Both the visible condition impact and possibly shared inflammatory mechanisms contribute. Effective treatment often improves mental health. For patients with substantial mental health impact, coordination with mental health providers is appropriate. We recognise the mental health dimensions of psoriasis.

Common triggers include: stress, streptococcal infections (particularly for guttate psoriasis), skin injury (Koebner phenomenon), certain medications (beta blockers, lithium, antimalarials), alcohol, smoking, weather changes, and hormonal changes. Identifying your specific triggers is a key part of practical management and is explored during consultation.

Do not stop prescribed medications without discussing with your prescribing physician. If medication triggers appear present, we can coordinate with your other physicians to consider alternatives where medically appropriate. Some medications with genuine benefits should continue with psoriasis treatment optimised around them.

Standard schedule varies by severity and treatment. After initial consultation: follow-up at 4–6 weeks, then 8–12 weeks during treatment optimisation. Once well-controlled, every 3–6 months typically. Biologic treatment patients require more frequent monitoring initially, then established intervals for injection administration and monitoring.

These specific presentations require specialist recognition and often specific treatment approaches. Scalp psoriasis: medicated shampoos, specific vehicle formulations. Nail psoriasis: often requires systemic or biologic treatment for significant improvement. Palmoplantar psoriasis: substantial functional impact often warranting more intensive treatment. Comprehensive consultation addresses these specific presentations.

Different conditions requiring different treatment. Psoriasis: autoimmune with characteristic thick red plaques and silvery scaling on typical areas (elbows, knees, scalp, lower back); different immune mechanism; different treatments including specific biologics. Eczema: barrier dysfunction with different presentation; different treatments. Sometimes confused clinically — specialist assessment provides accurate diagnosis.

DHA-licensed consultant dermatologists with substantial psoriasis expertise, comprehensive assessment including systemic implications (psoriatic arthritis, cardiovascular, mental health), access to the full range of modern biologic treatments, insurance authorisation support, transparent pricing, direct-billing insurance, sustained partnership approach, multilingual capability, and coordination with rheumatology for psoriatic arthritis when appropriate.

Three ways: WhatsApp us for fastest response, call direct booking 9 AM to 9 PM seven days a week, or book online. For your first appointment please bring: photos of psoriasis at its worst if available, list of all treatments you have tried, list of current medications, insurance card, previous medical reports, and specific questions. Comprehensive first consultation supports informed treatment planning.

VISIT US

Where psoriasis treatment happens at Vedara Care JVC.

Al Barsha South Fourth, Binghatti Azure, Shop -4,
Jumeraih Village Circle (JVC) Dubai
Operating Hours
Monday–Sunday: 8:30 am to 11:30 pm

Nearby Landmarks

Walking distance from Circle Mall
3 minutes from FIVE Jumeirah Village Hotel
5 minutes from JSS Private School
Free patient parking
Easy access from Sheikh Mohammed Bin Zayed Road & Al Khail Road

Our JVC clinic has dedicated consultation rooms for comprehensive psoriasis assessment, specialised treatment areas, biologic treatment administration facilities, and a comfortable environment recognising the sustained-partnership nature of psoriasis treatment.

Book Psoriasis Consultation

READY TO TRANSFORM YOUR PSORIASIS?

Clear or nearly clear skin is achievable. Let us help you get there.

Whether you have chronic plaque psoriasis affecting substantial areas of your body, scalp or nail psoriasis with cosmetic impact, palmoplantar psoriasis affecting your work, or you are considering modern biologic treatments after inadequate previous therapy — comprehensive specialist consultation is the right starting point. Same-week appointments typically available at our JVC clinic.

Initial consultation from AED [X] · Walking distance from Circle Mall, JVC · DHA-licensed consultant dermatologists · 400+ psoriasis patients treated · Access to full range of modern biologic treatments · Comprehensive systemic assessment · Multiple languages · Insurance direct-billing with biologic authorisation support